DUBLIN--(BUSINESS WIRE)--The "Primary Cells Market Share, Size, Trends, Industry Analysis Report, By Type; By End-Use; By Source; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

The global primary cells market size is expected to reach USD 1.79 billion by 2028 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing investments in biomedical research coupled with growth in the occurrence of diseases such as cancer drive the growth of the primary cell culture market. Increasing demand for advanced drug development and testing, growing applications in genetic engineering and virology, and stringent regulations regarding animal testing boost the growth of this market.

The significant growth in healthcare and pharmaceutical sectors, technological advancements, and growing use of primary cells in stem cell therapy are some factors expected to provide growth opportunities during the forecast period. The different types of primary cells include hematopoietic, hepatocytes, renal cells, gastrointestinal cells, skin cells, lung cells, and others. There has been a high demand for hematopoietic cells, which are derived from blood and bone marrow.

The demand for human primary cells was high in 2019. Human primary cells exhibit the functional and morphological characteristics of their tissue of origin. Human primary cells are increasingly being used in cancer research, and drug discovery. Other applications driving the growth of this segment include 3D cell culture, drug screening, and toxicity testing, monoclonal antibodies, and genetic engineering.

The increasing use of these cells for treatment and research associated with cancer, coupled with technological advancements drives the market growth. Hematopoietic primary cells are increasingly being used in stem cell therapy, vaccine development, and the study of tissue and organ replacement, thereby boosting the growth of this segment.

The demand for primary cells has increased from pharmaceutical and biotechnology companies for applications such as research and development, drug discovery, testing of new drugs, cosmetics, and chemicals, and analyzing of maximum permissible dosage of new drugs. The increasing investments in biomedical research, coupled with government initiatives support the growth of this segment.

North America dominated the global primary cell culture market in 2020 and is expected to maintain its dominance over the forecast period. Growing advancements in cancer research, significant investment in healthcare services, and the increasing occurrence of cancer-related disorders support market growth in this region. The increasing geriatric population coupled with government initiatives and programs, and emerging healthcare and pharmaceutical sectors fuel growth in this region.

Key Topics Covered:

1. Chapter 1. Introduction

2. Chapter 2. Executive Summary

3. Chapter 3. Research Methodology

4. Chapter 4. Primary Cells Market Insights

4.1. Primary Cells - Industry snapshot

4.2. Primary Cells Market Dynamics

4.3. Porter's Five Forces Analysis

4.4. Primary Cells Market PESTLE Analysis

4.5. Value Chain Analysis

4.6. Competitive Ranking Analysis, 2020

5. Chapter 5. Primary Cells Market Assessment by Source

5.1. Introduction

5.2. Animal Primary Cells

5.3. Human Primary Cells

6. Chapter 6. Primary Cells Market Assessment by Type

6.1. Introduction

6.2. Hematopoietic

6.3. Hepatocytes

6.4. Renal Cells

6.5. Gastrointestinal Cells

6.6. Skin Cells

6.7. Lung Cells

6.8. Others

7. Chapter 7. Primary Cells Market Assessment by End-User

7.1. Introduction

7.2. Medical

7.3. Pharmaceutical and Biotechnology Companies

7.4. Research Institutes

7.5. Others

8. Chapter 8. Primary Cells Market Assessment by Geography

8.1. Introduction

8.2. Primary Cells Market - North America

8.3. Primary Cells Market - Europe

8.4. Primary Cells Market - Asia-Pacific

8.5. Primary Cells Market - Latin America

8.6. Primary Cells Market - Middle East and Africa

9. Chapter 9. Competitive Landscape

9.1. Expansion and Product Launch Analysis

9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Chapter 10. Company Profiles

10.1. Cell Biologics, Inc.

10.2. ZenBio, Inc.

10.3. Stem Cell Technologies

10.4. Sigma-Aldrich

10.5. Thermo Fisher Scientific

10.6. Cureline

10.7. American Type Culture Collection

10.8. Cell Applications, Inc.

10.9. Pelobiotech

10.10. Merck KGaA

10.11. Axol Bioscience Ltd

10.12. Promocell

10.13. ALLCells

10.14. Lonza Group, AG

10.15. Creative Bioarray

For more information about this report visit https://www.researchandmarkets.com/r/13qwgg

Read the original:

Insights on the Primary Cells Global Market to 2028 - by Type, End-use, Source and Regions - ResearchAndMarkets.com - Business Wire

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *